Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study

Digestive and Liver Disease

Volumn 48, Issue 6, 2016, Pages 592-600

  Van Assche, Gert ^a   Peyrin Biroulet, Laurent ^b   Sturm, Andreas ^c   Gisbert, Javier P ^d   Gaya, Daniel R ^e   Bokemeyer, Bern ^f   Mantzaris, Gerassimos J ^g   Armuzzi, Alessandro ^h   Sebastian, Shaji ⁱ   Lara, Nuria ^j   Lynam, Mark ^j   Rojas Farreras, Sonia ^j   Fan, Tao ^k   Ding, Qian ^k   Black, Christopher M ^k   Kachroo, Sumesh ^k  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c German Red Cross Hospital   (Germany)

^d Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^e GLASGOW ROYAL INFIRMARY   (United Kingdom)

^f KLINIKUM MINDEN   (Germany)

^g EVANGELISMOS HOSPITAL   (Greece)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^j IQVIA   (United States)

^k MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

Control of disease; Health related quality of life; Inflammatory bowel disease; Unmet needs

Indexed keywords

MESALAZINE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE SEVERITY; EUROQOL 5D 5L QUESTIONNAIRE; FEMALE; HEALTH CARE NEED; HUMAN; MAJOR CLINICAL STUDY; MALE; MAYO SCORE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCEPTION; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; RETROSPECTIVE STUDY; SCORING SYSTEM; SHORT INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; ULCERATIVE COLITIS; VISUAL ANALOG SCALE; WORK PRODUCTIVITY AND ACITIVITY IMPAIRMENT IN ULCERATIVE COLITIS QUESTIONNAIRE; CLINICAL TRIAL; COLITIS, ULCERATIVE; EUROPE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATIENT-REPORTED OUTCOME; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT REPORTED OUTCOME MEASURES; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84959250544     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.01.011     Document Type: Article

References (40)

1. Cima R.R., Pemberton J.H. Medical and surgical management of chronic ulcerative colitis. Archives of Surgery 2005, 140:300-310.
2. Neuman M.G. Immune dysfunction in inflammatory bowel disease. Translational Research 2007, 149:173-186.
3. Molodecky N.A., Soon I.S., Rabi D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142. 46-54.e42; quiz e30.
4. Marchioni Beery R., Kane S. Current approaches to the management of new-onset ulcerative colitis. Clinical and Experimental Gastroenterology 2014, 7:111-132.
5. Cohen R., Skup M., Ozbay A.B., et al. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US. Journal of Medical Economics 2015, 18:447-456.
6. Ochsenkühn T., D'Haens G. Current misunderstandings in the management of ulcerative colitis. Gut 2011, 60:1294-1299.
7. Casellas F., López-Vivancos J., Badia X., et al. Influence of inflammatory bowel disease on different dimensions of quality of life. European Journal of Gastroenterology and Hepatology 2001, 13:567-572.
8. Cohen R.D., Yu A.P., Wu E.Q., et al. Systematic review: the costs of ulcerative colitis in Western countries. Alimentary Pharmacology and Therapeutics 2010, 31:693-707.
9. ECCO European Crohn's and Colitis Organization Guidelines: Second European evidence-based consensus on the diagnosis and management of ulcerative colitis 2012, [accessed 02.09.15]. https://www.ecco-ibd.eu/index.php/publications/ecco-guidelines-science/published-ecco-guidelines.html.
10. Han S.W., Gregory W., Nylander D., et al. The SIBDQ: further validation in ulcerative colitis patients. American Journal of Gastroenterology 2000, 95:145-151.
11. Bokemeyer B., Hardt J., Hüppe D., et al. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry. Journal of Crohn's and Colitis 2013, 7:355-368.
12. Sandborn W.J., Hanauer S., Van Assche G., et al. Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases. Journal of Crohn's and Colitis 2014, 8:927-935.
13. Bewtra M., Brensinger C.M., Tomov V.T., et al. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index. Inflammatory Bowel Diseases 2014, 20:1070-1078.
14. Herdman M., Gudex C., Lloyd A., et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research 2011, 20:1727-1736.
15. Euroqol publications. (accessed 2 September 2015). http://www.euroqol.org/about-eq-5d/publications.html.
16. Atkinson M.J., Sinha A., Hass S.L., et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes 2004, 2:12.
17. Reilly M.C., Zbrozek A.S., Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993, 4:353-365.
18. Blonski W., Buchner A.M., Lichtenstein G.R. Treatment of ulcerative colitis. Current Opinion in Gastroenterology 2014, 30:84-96.
19. Frøslie K.F., Jahnsen J., Moum B.A., et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007, 133:412-422.
20. Solberg I.C., Lygren I., Jahnsen J., et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scandinavian Journal of Gastroenterology 2009, 44:431-440.
21. Levin B., Lennard-Jones J., Riddell R.H., et al. Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bulletin of the World Health Organization 1991, 69:121-126.
22. Schreiber S., Panés J., Louis E., et al. Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey. BMC Gastroenterology 2012, 12:108.
23. Hendrickson B.A., Gokhale R., Cho J.H. Clinical aspects and pathophysiology of inflammatory bowel disease. Clinical Microbiology Reviews 2002, 15:79-94.
24. Burisch J., Weimers P., Pedersen N., et al. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease - an ECCO-EpiCom study. Journal of Crohn's and Colitis 2014, 8:1030-1042.
25. Sandborn W.J., Feagan B.G., Marano C., et al. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2014, 146. 96-109.e1.
26. Theede K., Dahlerup J.F., Fallingborg J., et al. Biologic therapy in inflammatory bowel disease. Danish Medical Journal 2013, 60:B4652.
27. Sandborn W.J., Feagan B.G., Marano C., et al. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2014, 146:85-95.
28. Shah E., Rezaie A., Riddle M., et al. Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence?. Annals of Gastroenterology 2014, 27:224-230.
29. Sajadinejad M.S., Molavi H., Asgari K., et al. Personality dimensions and type D personality in female patients with ulcerative colitis. International Journal of Research in Medical Sciences 2012, 17:898-904.
30. Boye B., Jahnsen J., Mokleby K., et al. The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?. Inflammatory Bowel Diseases 2008, 14:680-686.
31. Reinisch W., Sandborn W.J., Bala M., et al. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflammatory Bowel Diseases 2007, 13:1135-1140.
32. Hjortswang H., Järnerot G., Curman B., et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. European Journal of Gastroenterology and Hepatology 2003, 15:1011-1020.
33. Gibson P.R., Vaizey C., Black C.M., et al. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. Journal of Crohn's and Colitis 2014, 8:598-606.
34. Hoivik M.L., Moum B., Solberg I.C., et al. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study. Inflammatory Bowel Diseases 2012, 18:1540-1549.
35. Colombel J., Reinisch W., Gibson P.R., et al. Clinical outcomes in continuous clinical responders with moderately to severely active ulcerative colitis: sub-analyses from the Pursuit-SC maintenance study 2014.
36. Williet N., Sandborn W.J., Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2014, 12. 1246-1256.e6.
37. Gray J.R., Leung E., Scales J. Treatment of ulcerative colitis from the patient's perspective: a survey of preferences and satisfaction with therapy. Alimentary Pharmacology and Therapeutics 2009, 29:1114-1120.
38. Kemp K., Griffiths J., Campbell S., et al. An exploration of the follow-up up needs of patients with inflammatory bowel disease. Journal of Crohn's and Colitis 2013, 7:e386-e395.
39. Rubin D.T., Siegel C.A., Kane S.V., et al. Impact of ulcerative colitis from patients' and physicians' perspectives: results from the UC: NORMAL survey. Inflammatory Bowel Diseases 2009, 15:581-588.
40. Goodhand J.R., Wahed M., Mawdsley J.E., et al. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflammatory Bowel Diseases 2012, 18:2301-2309.